Myositis Clinical Trials
Clinical Trials for Myositis are in need of patients. Rare Disease patients are often difficult to find. We hope you will consider current and new clinical trial opportunities.
Search trials for Dermatomyositis, Polymyositis, Inclusion Body Myositis, Necrotizing Autoimmune Myopathy, Juvenile Dermatomyositis, Juvenile Polymyositis, Inflammatory Myopathy, and any other illnesses you have.
We have partnered with Antidote Technologies to make clinical trial matching faster, more refined through the search tool, and by providing you will all of the information you need to make a decision to participate in a clinical trial. And, the trials are easy to read adding a huge benefit. To begin your trial match, click the start button below.
NOTE: All trials listed on ClinicalTrials.gov are included in the clinical trial matching tool above.
Clinical Trials 101
Understanding how clinical trials work to find the right fit for you
Lindsey Wahlstrom-Edwards, Head of Partnerships with Antidote Technologies joined us live for this session to educate us about how clinical trials work and about using the Match tool to find a clinical trial.
We have partnered with Orphazyme
Orphazyme for the phase II/III arimoclomol clinical trial for sporadic inclusion body myositis.
We have partnered with Corbus:
Corbus Pharmaceuticals: DETERMINE, a Phase 3 trial designed to evaluate the efficacy and safety of lenabasum for the treatment of adults with dermatomyositis.
We have partnered with UCB / Ra Pharma
RA101495-02.202: A Phase 2 Study of Zilucoplan in Patients with Immune-Mediated Necrotizing Myopathy.
We have partnered with Kezar
KZR-616: A Phase 2 Study of KZR-616 in Patients with polymyositis, dermatomyositis, and immune-mediated necrotizing myopathy.